Candel Therapeutics Inc
NASDAQ:CADL 4:00:00 PM EDT
Market Cap (Intraday) | 45.69M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $1.53 |
50-Day MA | $1.51 |
200-Day MA | $1.21 |
Candel Therapeutics Inc Stock, NASDAQ:CADL
117 Kendrick Street, Suite 450, Needham, Massachusetts 02494
United States of America
Phone: +1.617.916.5445
Number of Employees: 76
Description
Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.